Senolytics are the first therapies that directly target one of the aging processes in order to delay or prevent age-related diseases, and they are now in human trials. Today, we think that it is the ideal time to have a look at how they work and what... https://t.co/Iopgt1OV5v— Lifespan.IO (@LifespanIO) December 27, 2018
And he shewed me a river of water of life, clear as crystal, proceeding from the throne of God and of the Lamb. In the midst of the street...
Thursday, December 27, 2018
"Senolytics" now in human trials